WEBINAR: Danger: Is AI making the first consultation a second opinion? – VIEW ON DEMAND

Cheap testing and fast AI answers provide unprecedented accessibility, but they do not inherently improve patient outcomes... and can sometimes worsen them.
Many patients now arrive at their first appointment with home-collected test results and an AI-generated interpretation already in hand. Patient-centric sampling and conversational AI have made diagnostics more accessible than ever, but access alone does not improve outcomes. Results without context can create false reassurance, unnecessary anxiety or delayed care. Drawing on fertility care as an example of complex care pathways, this panel discusses how remote diagnostics, lab innovation, and AI can be used to redesign integrated patient journeys and improve the outcomes that matter for both patients and clinicians.
What you will learn:
- Remote diagnostics: what patients told us about capillary versus venous sampling, and what labs need before they trust a sample collected at home
- Data, decisions and dangers: when cheap tests and AI chatbot answers help patients, and when they cause false reassurance, anxiety or delay
- Interpretation vs diagnosis: where explaining a result ends and diagnosing begins, and who is accountable when AI gets it wrong
- Unblocking the journey: what is really stopping remote diagnostics becoming routine, and how telemedicine and well-governed AI can improve outcomes today
Speakers
Andreia Trigo BSc MSc RN ANP
Co-Founder and Chief Executive Officer, Enhanced Fertility and EnhancedDx

Andreia Trigo is Chief Executive Officer and Clinical Director of EnhancedDx. An Advanced Nurse Practitioner with more than 20 years of nursing experience across perioperative care, pain medicine and clinical research, she founded Enhanced Fertility in 2020 to improve access to personalised fertility care through data, AI and remote diagnostics. She previously led mHealth research on patient-reported outcomes at University College London Hospitals and taught on De Montfort University's MSc in Advanced Practice. A TEDx speaker and recipient of King's College London's Distinguished Alumni Entrepreneurship Award, she is a member of the British Fertility Society, American Society for Reproductive Medicine and the European Society for Human Reproduction & Embryology.
Carlos Sousa PhD
Molecular Biology Director, SYNLAB Portugal

Carlos Rafael Sousa is Molecular Biology Director at SYNLAB Portugal, based in Porto. A microbiologist with more than 25 years in molecular diagnostics, he has led molecular biology laboratories in pathology and clinical settings, with particular expertise in high-risk HPV detection, molecular microbiology, virology and research into host DNA methylation in cervical cancer. He has extensive experience implementing and maintaining ISO 15189 and ISO 9001 quality systems, giving him a practical view of what laboratories need before they can validate and trust new sample types and testing pathways.
Carol Lynn Curchoe PhD, HCLD
Director of Science and Innovation, Progenesis

Carol Lynn Curchoe is a reproductive physiologist and High Complexity Laboratory Director who builds and directs IVF laboratories. She is currently the Director of Science and Innovation at Progenesis, where she integrates genetics, AI-driven analytics, EMR systems and connected laboratory technologies, and has served as an IVF Laboratory Director for multiple leading US clinics. She chaired the American Society for Reproductive Medicine's Artificial Intelligence Special Interest Group from 2023 to 2024 and founded ART Compass, a quality management platform for IVF laboratories. A former Utah State Science Advisor, author and expert in genetics and laboratory innovation.
Frank Khan Sullivan
Co-Founder and Chief Technology Officer, EnhancedDx

Frank Khan Sullivan is Co-Founder and Chief Technology Officer of Enhanced Fertility and EnhancedDx, and the original architect of the EnhancedDx clinical AI platform, which connects remote testing, laboratory results and clinical decision support. He designed the Open Patient Summary Record to give patients control and portability of their clinical data, and previously co-founded a cardiac and respiratory diagnostics clinic in the UK. His earlier career includes Microsoft, Rackspace and leading data at CSO at Publicis Groupe UK until 2022. He has served as a guest lecturer and executive MBA mentor at ESSEC Business School in Paris, and is an allied member of ASRM and ESHRE with experience in informatics and artificial intelligence.
Moderator
Founder, Patient Centric Sampling Interest Group
Located in Hertford, UK, Neil is the Chair and co-founder of the PCSIG. He also runs a consultancy company where one of the main drivers is to help Clients understand the benefits of patient centric blood sampling, develop appropriate technologies and workflows and implement them for the benefit of human wellbeing. Neil’s interest in these technologies began in 2007 whilst leading efforts at GlaxoSmithKline to find blood sampling and analysis approaches suitable for the measurement of pharmaceutical concentrations in samples obtained from children.
Sponsor information
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
Altasciences: Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
Alturas Analytics: Alturas Analytics provides expert GLP & non-GLP LC-MS/MS and GC-MS/MS bioanalytical and PK/TK analysis services of small and large molecules in any matrix for discovery through Phase IV clinical trials.
Artyc: Artyc's battery-powered cold chain packaging is purpose-built for remote microsample collection, featuring precise temperature and location monitoring to safely enable a wider range of tests (e.g., refrigerated) in remote settings.
BD: One of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Bento Biology Platforms: A leading self-service biosampling company, transforming the decentralized clinical trial and biorepository landscape. Bento’s Biology Boxes deliver best-in-class biosampling and biosensing tools to each patient’s doorstep and guide them every step of the way with 24/7 live support, all backed by a hyper-kitting facility and sophisticated kitting logistics software. Created and vetted with participant input all along the design path, powered by game economies and participate-to-earn wallet technology, our digital symptom diaries (PROMs) and pharmacovigilance tools build trust across all medical communities while also radically reducing costs, accelerating time-to-market, and significantly lowering cost per-patient-visit.
Boehringer Ingelheim: Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. Every day our scientists are charting new territory and continuing our commitment to innovation that has created exceptional medicines that have changed the lives of millions of patients. We embrace the power of partnership and diversity of minds across the life-science communities to realize even more innovation and incubate new ideas.”
Capitainer: Dried blood spots (DBS) is now quantitative with volumetric control through our microfluidic qDBS technology solution. Precision, accuracy, sample protection and ease of use both at sampling and in the lab are key features for us in all product development.
Celerion: A world-class bioanalytical CRO dedicated to advancing drug development through cutting-edge science and patient-focused solutions. With decades of expertise, we are at the forefront of patient-centric sampling, pushing the boundaries of sensitivity to reduce sample size while maximizing the value of every precious drop of patient blood. Our mission is to ensure that each sample contributes meaningfully to the research and development of new therapies, enabling faster and more accurate insights into drug efficacy and safety. Through innovative approaches and a commitment to excellence, we are proud to support research that brings life-changing medicines to patients worldwide.
Charles River: Charles River Laboratories are a leading drug discovery and development contract research organization providing a broad spectrum of laboratory and data science support to the clinical development industry. This includes bioanalytical chemistry, immunology, biomarker services, immunoassay, genomics, vaccine development and ADME services. With over 1000 dedicated laboratory colleagues across a global footprint and expertise in traditional and advanced modalities, Charles River Laboratories are well placed to leverage scale and scope to support Clinical programs carried out anywhere in the world.
Genentech: Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit gene.com.
GSK: We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
IQVIA Laboratories: IQVIA Laboratories is a leading drug discovery and development laboratory services organization providing innovative solutions that encompass broad central laboratory and specialty biomarker services, including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions. Through the Decentralized Clinical Trials group, IQVIA Laboratories is at the forefront of patient-centric sampling, offering a variety of self-collection methodologies and is validating multiple assays using micro-samples that are self-collected by study participants.
LetsGetChecked: Healthcare that meets your people where they are. We enable partners to seamlessly utilize at-home healthcare programs to reduce barriers to access for those most in need.
Neoteryx: Neoteryx, a Trajan Scientific and Medical brand, offers remote microsampling devices designed for easy, reliable, cost-effective specimen collection in the clinic or field by healthcare professionals and end-users. Our innovative tools support decentralized research, remote monitoring, and personalized medicine, enabling streamlined sample collection and lab anaysis for pharmaceutical, clinical, and research sectors. Products like the Mitra® with gold-standard VAMS® technology for biological fluid sampling and the Harpera™ Microbiopsy Punch for skin sampling provide convenient, cost-effective solutions for advancing human health.
RDi: Leveraging our expertise in data processing, technology, and automation, we are revolutionising the healthcare supply chain. Through fulfilment and traceable kitting, we’re changing the way pharmaceutical and medical companies operate and deliver as part of the medical supply chain.
RedDrop Dx: Next generation blood sampling solutions.
Resolian: Global bioanalytical and analytical sciences partner supporting drug development and multi-regional clinical trials. Resolian is a leading global Contract Research Organization providing specialized services in GxP and non-regulated bioanalysis, drug metabolism/pharmacokinetic, and GMP CMC analytical and materials science. Comprised of the former Alliance Pharma, Inc., Drug Development Solutions Ltd, and Denali Medpharma labs and powered by a team of more than 500 experts across the US, UK, Australia, and China, Resolian supports pharma and biotech companies’ programs throughout the entire drug development continuum.
Roche: Doing now what patients need next.
SampleFacts: SampleFacts is a company that specializes in providing dried blood spot (DBS) sampling. We offer a solution that enables instant separation of blood cells and plasma from a single drop of blood. With these characteristics the product facilitates the opportunity to provide a reliable and efficient method for collecting and storing blood samples, addressing the growing demand for remote sampling and biobanking.
Streck: Established in 1971, Streck develops quality control and sample stabilization products that give clinical and research laboratories worldwide confidence in the validity of their results and help make the world safer, healthier and more productive. Streck products are manufactured in La Vista, Nebraska, and delivered to thousands of labs across the globe.
Takeda: We exist to create better health for people and a brighter future for the world. While the science and technology we advance are constantly evolving, our ambition remains. We move science forward, so we can transform more lives.
Tasso: Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time.
Unilabs York Bioanalytical Solutions is a specialist provider of bioanalytical, metabolism and biomarker services to pharmaceutical and biotech companies, supporting development of small and large molecule therapeutics from discovery through to post-marketing.
Veloxity Labs: Veloxity Labs is a CRO focused on LC-MS bioanalysis. Our company is employee owned and operated, and offers start-up times and turn-around times in days by maintaining 80% capacity.
In association with
For more info on the PCSIG, please visit www.pcsig.org and follow on LinkedIn here.
If you are interested in partnering with The Evidence Base for future webinars, please contact [email protected].

























